Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


21 octubre 2014

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Structural Heart Disease. Costs of Periprocedural Complications in Patients Treated With Transcatheter Aortic Valve Replacement. Results From the Placement of Aortic Transcatheter Valve Trial

Suzanne V. Arnold, MD, MHA, Yang Lei, MS, Matthew R. Reynolds, MD, MSc, Elizabeth A. Magnuson, ScD, Rakesh M. Suri, MD, DPhil, E. Murat Tuzcu, MD, John L. Petersen II, MD, MHS, Pamela S. Douglas, MD, Lars G. Svensson, MD, PhD, Hemal Gada, MD, MBA, Vinod H. Thourani, MD, Susheel K. Kodali, MD, Michael J. Mack, MD, Martin B. Leon, MD and David J. Cohen, MD, MSc; on behalf of the PARTNER Investigators

Background: In patients with severe aortic stenosis, transcatheter aortic valve replacement (TAVR) improves survival when compared with nonsurgical therapy but with higher in-hospital and lifetime costs. Complications associated with TAVR may decrease with greater experience and improved devices, thereby reducing the overall cost of the procedure. Therefore, we sought to estimate the effect of periprocedural complications on in-hospital costs and length of stay of TAVR.

05 mayo 2014

EUROPEAN HEART JOURNAL. Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients

Ricardo Allende, John G. Webb, Antonio J. Munoz-Garcia, Peter de Jaegere, Corrado Tamburino, Antonio E. Dager, Asim Cheema, Vicenç Serra, Ignacio Amat-Santos, James L. Velianou, Marco Barbanti, Danny Dvir, Juan H. Alonso-Briales, Rutger-Jan Nuis, Elhamula Faqiri, Sebastiano Imme, Luis Miguel Benitez, Angela Maria Cucalon, Hatim Al Lawati, Bruno Garcia del Blanco, Javier Lopez, Madhu K. Natarajan, Robert DeLarochellière, Marina Urena, Henrique B. Ribeiro, Eric Dumont, Luis Nombela-Franco, Josep Rodés-Cabau

Aim: The aim of this study was to determine the effects of advanced chronic kidney disease (CKD) on early and late outcomes after transcatheter aortic valve implantation (TAVI), and to evaluate the predictive factors of poorer outcomes in such patients.

05 mayo 2014

EUROPEAN HEART JOURNAL. Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial

A. Michael Lincoff, Matthew Roe, Philip Aylward, John Galla, Andrzej Rynkiewicz, Victor Guetta, Michael Zelizko, Neal Kleiman, Harvey White, Ellen McErlean, David Erlinge, Mika Laine, Jorge Manuel dos Santos Ferreira, Shaun Goodman, Shamir Mehta, Dan Atar, Harry Suryapranata, Svend Eggert Jensen, Tamas Forster, Antonio Fernandez-Ortiz, Danny Schoors, Peter Radke, Guido Belli, Danielle Brennan, Gregory Bell, Mitchell Krucoff

Aims: Delcasertib is a selective inhibitor of delta-protein kinase C (delta-PKC), which reduced infarct size during ischaemia/reperfusion in animal models and diminished myocardial necrosis and improved reperfusion in a pilot study during primary percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (STEMI).

28 marzo 2014

EUROPEAN HEART JOURNAL. Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantation

Giulio G. Stefanini, Stefan Stortecky, Davide Cao, Julie Rat-Wirtzler, Crochan J. O´Sullivan, Steffen Gloekler, Lutz Buellesfeld, Ahmed A. Khattab, Fabian Nietlispach, Thomas Pilgrim, Christoph Huber, Thierry Carrel, Bernhard Meier, Peter Jüni, Peter Wenaweser, Stephan Windecker

Aim: The aim of this study was to evaluate whether coronary artery disease (CAD) severity exerts a gradient of risk in patients with aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI).

28 marzo 2014

EUROPEAN HEART JOURNAL. Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-centre ADVANCE Study

Axel Linke, Peter Wenaweser, Ulrich Gerckens, Corrado Tamburino, Johan Bosmans, Sabine Bleiziffer, Daniel Blackman, Ulrich Schäfer, Ralf Müller, Horst Sievert, Lars Søndergaard, Silvio Klugmann, Rainer Hoffmann, Didier Tchétché, Antonio Colombo, Victor M. Legrand, Francesco Bedogni, Pascal lePrince, Gerhard Schuler, Domenico Mazzitelli, Christos Eftychiou, Christian Frerker, Peter Boekstegers, Stephan Windecker, Friedrich-Wilhelm Mohr, Felix Woitek, Rüdiger Lange, Robert Bauernschmitt, Stephen Brecker

Aim: Transcatheter aortic valve implantation has become an alternative to surgery in higher risk patients with symptomatic aortic stenosis. The aim of the ADVANCE study was to evaluate outcomes following implantation of a self-expanding transcatheter aortic valve system in a fully monitored, multi-centre ‘real-world’ patient population in highly experienced centres.

05 marzo 2014

EUROPEAN HEART JOURNAL. Acquired thrombocytopenia after transcatheter aortic valve replacement: clinical correlates and association with outcomes

Danny Dvir, Philippe Généreux, Israel M. Barbash, Susheel Kodali, Itsik Ben-Dor, Mathew Williams, Rebecca Torguson, Ajay J. Kirtane, Sa´ar Minha, Salem Badr, Lakshmana K. Pendyala, Joshua P. Loh, Petros G. Okubagzi, Jessica N. Fields, Ke Xu, Fang Chen, Rebecca T. Hahn, Lowell F. Satler, Craig Smith, Augusto D. Pichard, Martin B. Leon, Ron Waksman

Aims: This study aimed to evaluate incidence and correlates for low platelet count after transcatheter aortic valve replacement (TAVR) and to determine a possible association between acquired thrombocytopenia and clinical outcomes.

22 abril 2014

EUROPEAN HEART JOURNAL. Paradoxical low-flow, low-gradient aortic stenosis despite preserved left ventricular ejection fraction: new insights from weights of operatively excised aortic valves

Marie-Annick Clavel, Nancy Côté, Patrick Mathieu, Jean G. Dumesnil, Audrey Audet, Andrée Pépin, Christian Couture, Dominique Fournier, Sylvain Trahan, Sylvain Pagé, Philippe Pibarot

Aims: We reported that patients with small aortic valve area (AVA) and low flow despite preserved left ventricular ejection fraction (LVEF), i.e. ‘paradoxical’ low flow (PLF), have worse outcomes compared with patients with normal flow (NF), although they generally have a lower mean gradient (MG). The aortic valve weight (AVW) excised at the time of valve replacement is a flow-independent marker of stenosis severity. The objective of this study was to compare the AVW of patients with PLF and MG<40 mmHg with the AVW of patients with NF and MG≥40 mmHg.

18 marzo 2014

EUROPEAN HEART JOURNAL. Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses

Gabor Toth, Michalis Hamilos, Stylianos Pyxaras, Fabio Mangiacapra, Olivier Nelis, Frederic De Vroey, Luigi Di Serafino, Olivier Muller, Carlos Van Mieghem, Eric Wyffels, Guy R. Heyndrickx, Jozef Bartunek, Marc Vanderheyden, Emanuele Barbato, William Wijns, Bernard De Bruyne

Aims: The present analysis addresses the potential clinical and physiologic significance of discordance in severity of coronary artery disease between the angiogram and fractional flow reserve (FFR) in a large and unselected patient population.

01 octubre 2014

AMERICAN HEART JOURNAL. Mortality after presentation with stent thrombosis is associated with time from index percutaneous coronary intervention: A report from the VA CART program

Ehrin J. Armstrong, MD, MS, Thomas M. Maddox, MD, MSc, Evan P. Carey, BS, Gary K. Grunwald, PhD, Kendrick A. Shunk, MD

Background: The risk of mortality for patients presenting to the cardiac catheterization laboratory with stent thrombosis (ST) may differ as a function of the timing from initial stent implantation. We hypothesized that the 30-day mortality would differ for angiographically defined early ST (EST), late ST (LST), and very late ST (VLST).

01 octubre 2014

AMERICAN HEART JOURNAL. Safety of coronary angiography and percutaneous coronary intervention via the radial versus femoral route in patients on uninterrupted oral anticoagulation with warfarin

Nevin C. Baker, DO, Erik W. O´Connell, DO, Wah Wah Htun, MD, Haiyan Sun, MS, Sandy M. Green, MD, Kimberly A. Skelding, MD, James C. Blankenship, MD, Thomas D. Scott, DO, Peter B. Berger, MD

Objective: To evaluate access site and other bleeding complications associated with radial versus femoral access in patients receiving oral anticoagulation (OAC) with warfarin.

01 septiembre 2014

AMERICAN HEART JOURNAL. Diagnostic accuracy of multidetector computed tomography coronary angiography in 325 consecutive patients referred for transcatheter aortic valve replacement

Daniele Andreini, MD, PhD, Gianluca Pontone, MD, Saima Mushtaq, MD, Antonio L. Bartorelli, MD, Giovanni Ballerini, MD, Erika Bertella, MD, Chiara Segurini, MD, Edoardo Conte, MD, Andrea Annoni, MD, Andrea Baggiano, MD, Alberto Formenti, MD, Laura Fusini, MS, Gloria Tamborini, MD, Francesco Alamanni, MD, Cesare Fiorentini, MD, Mauro Pepi, MD

Background: Multidetector computed tomography (MDCT) provides detailed assessment of valve annulus and iliofemoral vessels in transcatheter aortic valve replacement (TAVR) patients. However, data on diagnostic performance of MDCT coronary angiography (MDCT-CA) are scarce. The aim of the study is to assess diagnostic performance of MDCT for coronary artery evaluation before TAVR.

01 noviembre 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. X-ray magnetic resonance fusion modality may reduce radiation exposure and contrast dose in diagnostic cardiac catheterization of congenital heart disease

Anas A. Abu Hazeem MD1,†, Yoav Dori MD, PhD1,2, Kevin K. Whitehead MD, PhD1,2, Matthew A. Harris MD1,2, Mark A. Fogel MD1,2, Matthew J. Gillespie MD1,2, Jonathan J. Rome MD1,2 andAndrew C. Glatz MD, MSCE1,2,3,*

Background: Radiation exposure in the pediatric population may increase the risk of future malignancy. Children with congenital heart disease who often undergo repeated catheterizations are at risk. One possible strategy to reduce radiation is to use X-ray Magnetic Resonance Fusion (XMRF) to facilitate cardiac catheterization.

01 noviembre 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Radiation reduction in pediatric and adult congenital patients during cardiac catheterization

Daniel A. Mauriello MD1, Kenneth A. Fetterly PhD2, Ryan J. Lennon MS3, Guy S. Reeder MD2, Nathaniel W. Taggart MD1, Donald J. Hagler MD1,2, Frank Cetta MD1,2 andAllison K. Cabalka MD1,*

Objectives: Our objective was to determine if technical changes combined with radiation safety initiatives reduced the radiation dose delivered to patients during congenital catheterization.

01 noviembre 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Percutaneous stenting of interrupted aortic arch to treat compressive myelopathy

Nagaraja Moorthy MD, DM*, Rajiv Ananthakrishna MD, DM andManjunath C. Nanjappa MD, DM

Neurological complications of coarctation of aorta include spontaneous SAH, intracerebral hemorrhage, and cerebral abscess. Interrupted aortic arch (IAA) present as compressive myelopathy is not known. We describe an adult male presenting to neurology department with progressive paraparesis and was detected to have IAA with intraspinal collaterals causing compressive myelopathy. He was successfully treated with percutaneous stenting of IAA with dramatic improvement in paraparesis. © 2014 Wiley Periodicals, Inc.

01 noviembre 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Stenting of the obstructed ductus venosus as emergency and bridging strategy in a very low birth weight infant with infradiaphragmatic total anomalous pulmonary venous connection

Barbara E.U. Burkhardt MD1, Brigitte Stiller MD, PhD2 andJochen Grohmann MD2,*

A very low birth weight neonate (1.2 kg) with total anomalous pulmonary venous connection and obstructed infracardiac pulmonary venous drainage was treated by stenting of the ductus venosus via a transjugular approach. With one reintervention to dilate an in-stent stenosis, the palliative stented situation stabilized the patient for as long as three months until definitive surgical correction at a weight of 2 kg. © 2014 Wiley Periodicals, Inc.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.